title: Selective tumor cell targeting by the disaccharide moiety of bleomycin.
abstract: In a recent study, the well-documented tumor targeting properties of the antitumor agent bleomycin (BLM) were studied in cell culture using microbubbles that had been derivatized with multiple copies of BLM. It was shown that BLM selectively targeted MCF-7 human breast carcinoma cells but not the "normal" breast cell line MCF-10A. Furthermore, it was found that the BLM analogue deglycobleomycin, which lacks the disaccharide moiety of BLM, did not target either cell line, indicating that the BLM disaccharide moiety is necessary for tumor selectivity. Not resolved in the earlier study were the issues of whether the BLM disaccharide moiety alone is sufficient for tumor cell targeting and the possible cellular uptake of the disaccharide. In the present study, we conjugated BLM, deglycoBLM, and BLM disaccharide to the cyanine dye Cy5**. It was found that the BLM and BLM disaccharide conjugates, but not the deglycoBLM conjugate, bound selectively to MCF-7 cells and were internalized. The same was also true for the prostate cancer cell line DU-145 (but not for normal PZ-HPV-7 prostate cells) and for the pancreatic cancer cell line BxPC-3 (but not for normal SVR A221a pancreas cells). The targeting efficiency of the disaccharide was only slightly less than that of BLM in MCF-7 and DU-145 cells and comparable to that of BLM in BxPC-3 cells. These results establish that the BLM disaccharide is both necessary and sufficient for tumor cell targeting, a finding with obvious implications for the design of novel tumor imaging and therapeutic agents.
authors: Center for BioEnergetics, Biodesign Institute, and Department of Chemistry & Biochemistry, Arizona State University, Tempe, Arizona 85287, USA.
authors: Zhiqiang
authors: Z
authors: Yu
authors: Ryan M
authors: RM
authors: Schmaltz
authors: Trevor C
authors: TC
authors: Bozeman
authors: Rakesh
authors: R
authors: Paul
authors: Michael J
authors: MJ
authors: Rishel
authors: Krystal S
authors: KS
authors: Tsosie
authors: Sidney M
authors: SM
authors: Hecht
mesh_terms: D001761:Bleomycin / Q000737:chemistry*; D004187:Disaccharides / Q000737:chemistry*; D005260:Female; D006801:Humans; D061986:MCF-7 Cells
chemical_list: D004187:Disaccharides; D001761:Bleomycin
references: J Natl Cancer Inst. 1981 May;66(5):807-11
references: 6164811
references: J Am Chem Soc. 2001 Jun 6;123(22):5167-75
references: 11457377
references: South Med J. 2003 Dec;96(12):1174-86
references: 14696868
references: Nat Chem Biol. 2008 Jan;4(1):7-11
references: 18084271
references: Biochemistry. 1993 Apr 27;32(16):4293-307
references: 7682845
references: Br J Radiol. 1977 Jul;50(595):508-12
references: 68793
references: J Am Chem Soc. 2006 Nov 22;128(46):14806-7
references: 17105281
references: J Clin Oncol. 1993 Jul;11(7):1300-5
references: 7686216
references: Cancer. 1976 Jan;37(1):36-42
references: 55300
references: J Am Chem Soc. 2009 Feb 25;131(7):2438-9
references: 19187019
references: Chem Biol. 2003 Jan;10(1):45-52
references: 12573697
references: Chem Rev. 1999 Sep 8;99(9):2797-816
references: 11749501
references: Br J Pharmacol. 2001 Mar;132(5):1102-10
references: 11226141
references: Nat Rev Cancer. 2005 Feb;5(2):102-12
references: 15685195
references: Radiology. 1977 Jun;123(3):687-94
references: 860022
references: Invest Radiol. 2006 Mar;41(3):354-62
references: 16481920
references: Radiology. 2008 Feb;246(2):508-18
references: 18180339
references: J Nucl Med. 1981 Sep;22(9):787-92
references: 6168750
references: Med Pediatr Oncol. 1975;1(1):11-21
references: 60694
references: Prog Nucleic Acid Res Mol Biol. 1994;49:313-52
references: 7532315
references: J Nat Prod. 2000 Jan;63(1):158-68
references: 10650103